We have located links that may give you full text access.
Journal Article
Review
A Clinical Review of Structural Damage in Psoriatic Arthritis for Dermatologists: From Pathogenesis to Ongoing Controversies.
Journal of the American Academy of Dermatology 2023 October 17
Psoriatic arthritis (PsA) is a chronic inflammatory disease that often goes unrecognized in patients with psoriasis. As a result, patients may develop significant structural damage before diagnosis and initiation of adequate treatment. Dermatologists are in a unique position to identify early signs and symptoms of PsA. Here we briefly review the pathogenesis of PsA, differences in PsA presentation within real-world dermatology practice versus rheumatology clinical trials, and imaging modalities that can be used to assess structural damage. We then discuss several ongoing controversies related to prediction, assessment, and treatment of PsA structural damage. Debated questions include: 1) Does subclinical enthesitis predict progression from psoriasis to PsA?, 2) Does methotrexate inhibit progression of structural damage?, 3) Does structural damage correlate with clinical disease activity?, and 4) Can progression from psoriasis to PsA be prevented? Evidence presented herein suggests that dermatologists, together with rheumatologists, can play important roles in the early diagnosis and treatment of PsA, thereby potentially preventing irreversible structural damage.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app